ALDH9A1
Basic information
Region (hg38): 1:165662216-165698562
Previous symbols: [ "ALDH7", "ALDH4", "ALDH9" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ALDH9A1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 25 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 2 | 0 |
Variants in ALDH9A1
This is a list of pathogenic ClinVar variants found in the ALDH9A1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-165663115-T-C | not specified | Uncertain significance (Aug 30, 2022) | ||
1-165663123-C-T | not specified | Uncertain significance (Mar 31, 2024) | ||
1-165663127-C-T | not specified | Uncertain significance (May 24, 2024) | ||
1-165663139-C-G | not specified | Uncertain significance (Oct 05, 2021) | ||
1-165667348-T-C | not specified | Uncertain significance (Jan 08, 2024) | ||
1-165667380-A-C | not specified | Uncertain significance (Dec 19, 2022) | ||
1-165667393-G-A | not specified | Uncertain significance (Apr 28, 2023) | ||
1-165667395-C-T | not specified | Uncertain significance (Dec 14, 2023) | ||
1-165668955-T-C | not specified | Uncertain significance (Jun 11, 2021) | ||
1-165668976-G-T | not specified | Uncertain significance (Jun 04, 2024) | ||
1-165668986-T-G | not specified | Likely benign (Feb 03, 2022) | ||
1-165669291-G-C | not specified | Uncertain significance (Sep 13, 2023) | ||
1-165669296-C-T | not specified | Uncertain significance (May 23, 2024) | ||
1-165669414-C-G | not specified | Uncertain significance (Dec 14, 2022) | ||
1-165669450-C-A | Uncertain significance (Nov 01, 2023) | |||
1-165679462-T-C | not specified | Uncertain significance (May 26, 2024) | ||
1-165679552-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
1-165680534-C-T | not specified | Uncertain significance (Feb 21, 2024) | ||
1-165680547-C-T | Likely benign (Apr 01, 2022) | |||
1-165680569-C-T | not specified | Uncertain significance (Apr 20, 2024) | ||
1-165680635-A-G | not specified | Uncertain significance (May 24, 2024) | ||
1-165682109-C-G | not specified | Uncertain significance (Apr 21, 2022) | ||
1-165682137-A-G | not specified | Uncertain significance (Dec 15, 2023) | ||
1-165682149-A-C | not specified | Uncertain significance (Jan 30, 2024) | ||
1-165682151-G-A | not specified | Uncertain significance (Oct 07, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ALDH9A1 | protein_coding | protein_coding | ENST00000354775 | 11 | 36648 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.10e-11 | 0.296 | 125619 | 0 | 129 | 125748 | 0.000513 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.416 | 312 | 292 | 1.07 | 0.0000144 | 3352 |
Missense in Polyphen | 117 | 110.34 | 1.0603 | 1297 | ||
Synonymous | -0.856 | 119 | 108 | 1.10 | 0.00000563 | 1029 |
Loss of Function | 1.01 | 20 | 25.5 | 0.783 | 0.00000141 | 297 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000392 | 0.000388 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000403 | 0.000381 |
Finnish | 0.00147 | 0.00143 |
European (Non-Finnish) | 0.000698 | 0.000668 |
Middle Eastern | 0.000403 | 0.000381 |
South Asian | 0.000105 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Converts gamma-trimethylaminobutyraldehyde into gamma- butyrobetaine. Catalyzes the irreversible oxidation of a broad range of aldehydes to the corresponding acids in an NAD-dependent reaction. {ECO:0000269|PubMed:10702312}.;
- Pathway
- Tryptophan metabolism - Homo sapiens (human);Pyruvate metabolism - Homo sapiens (human);Arginine and proline metabolism - Homo sapiens (human);Glycolysis / Gluconeogenesis - Homo sapiens (human);Glycerolipid metabolism - Homo sapiens (human);beta-Alanine metabolism - Homo sapiens (human);Lysine degradation - Homo sapiens (human);Histidine metabolism - Homo sapiens (human);Fatty acid degradation - Homo sapiens (human);Ascorbate and aldarate metabolism - Homo sapiens (human);Valine, leucine and isoleucine degradation - Homo sapiens (human);Carnitine Synthesis;GABA receptor Signaling;Tryptophan metabolism;Branched-chain amino acid catabolism;Glutamate Glutamine metabolism;Metabolism of amino acids and derivatives;Tyrosine metabolism;Glycolysis and Gluconeogenesis;Leukotriene metabolism;Metabolism;Lysine degradation;Propanoate metabolism;Histidine metabolism;Lysine metabolism;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine;Valine, leucine and isoleucine degradation;Bile acid biosynthesis;Glycerophospholipid metabolism;Arginine Proline metabolism;Carnitine synthesis;Pyruvate metabolism;Tryptophan degradation;L-carnitine biosynthesis;Valine Leucine Isoleucine degradation;Histidine degradation;Validated targets of C-MYC transcriptional repression
(Consensus)
Recessive Scores
- pRec
- 0.247
Intolerance Scores
- loftool
- 0.405
- rvis_EVS
- -0.02
- rvis_percentile_EVS
- 52.15
Haploinsufficiency Scores
- pHI
- 0.0437
- hipred
- N
- hipred_score
- 0.289
- ghis
- 0.468
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.536
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Aldh9a1
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- cellular aldehyde metabolic process;neurotransmitter biosynthetic process;hormone metabolic process;carnitine biosynthetic process;oxidation-reduction process
- Cellular component
- cytoplasm;cytosol;extracellular exosome
- Molecular function
- 3-chloroallyl aldehyde dehydrogenase activity;aldehyde dehydrogenase (NAD) activity;aminobutyraldehyde dehydrogenase activity;1-pyrroline dehydrogenase activity;glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity;4-trimethylammoniobutyraldehyde dehydrogenase activity